Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. [electronic resource]
Producer: 20021223Description: 48-56 p. digitalISSN:- 1600-6135
- Adult
- Antibodies, Monoclonal -- adverse effects
- Antilymphocyte Serum -- adverse effects
- Basiliximab
- Creatinine -- blood
- Cyclosporine -- pharmacokinetics
- Drug Therapy, Combination
- Female
- France
- Graft Rejection -- epidemiology
- Humans
- Immunosuppression Therapy -- methods
- Kidney Failure, Chronic -- etiology
- Kidney Transplantation -- immunology
- Male
- Middle Aged
- Mycophenolic Acid -- analogs & derivatives
- Racial Groups
- Recombinant Fusion Proteins
- Safety
- Time Factors
- Tissue Donors -- statistics & numerical data
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.